Literature DB >> 29694246

Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosimetry Platform.

Abigail E Besemer1,2, You Ming Yang1,3, Joseph J Grudzinski1, Lance T Hall4,5, Bryan P Bednarz1.   

Abstract

This work describes the development and validation of a patient-specific Monte Carlo internal dosimetry platform called RAPID (Radiopharmaceutical Assessment Platform for Internal Dosimetry). RAPID utilizes serial PET/CT or SPECT/CT images to calculate voxelized three-dimensional (3D) internal dose distributions with the Monte Carlo code Geant4. RAPID's dosimetry calculations were benchmarked against previously published S-values and specific absorbed fractions (SAFs) calculated for monoenergetic photon and electron sources within the Zubal phantom and for S-values calculated for a variety of radionuclides within spherical tumor phantoms with sizes ranging from 1 to 1000 g. The majority of the S-values and SAFs calculated in the Zubal Phantom were within 5% of the previously published values with the exception of a few 10 keV photon SAFs that agreed within 10%, and one value within 16%. The S-values calculated in the spherical tumor phantoms agreed within 2% for 177Lu, 131I, 125I, 18F, and 64Cu, within 3.5% for 211At and 213Bi, within 6.5% for 153Sm, 111In, 89Zr, and 223Ra, and within 9% for 90Y, 68Ga, and 124I. In conclusion, RAPID is capable of calculating accurate internal dosimetry at the voxel-level for a wide variety of radionuclides and could be a useful tool for calculating patient-specific 3D dose distributions.

Entities:  

Keywords:  Monte Carlo; internal dosimetry; radiopharmaceuticals; targeted radionuclide therapy

Mesh:

Substances:

Year:  2018        PMID: 29694246      PMCID: PMC5963670          DOI: 10.1089/cbr.2018.2451

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  44 in total

1.  Comparison of I-131 radioimmunotherapy tumor dosimetry: unit density sphere model versus patient-specific Monte Carlo calculations.

Authors:  David M Howard; Kimberlee J Kearfott; Scott J Wilderman; Yuni K Dewaraja
Journal:  Cancer Biother Radiopharm       Date:  2011-09-22       Impact factor: 3.099

2.  Recovery of total I-131 activity within focal volumes using SPECT and 3D OSEM.

Authors:  Kenneth F Koral; Anastasia Yendiki; Yuni K Dewaraja
Journal:  Phys Med Biol       Date:  2007-01-16       Impact factor: 3.609

3.  177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy.

Authors:  Michael Garkavij; Mattias Nickel; Katarina Sjögreen-Gleisner; Michael Ljungberg; Tomas Ohlsson; Karin Wingårdh; Sven-Erik Strand; Jan Tennvall
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

4.  Collapsed cone convolution of radiant energy for photon dose calculation in heterogeneous media.

Authors:  A Ahnesjö
Journal:  Med Phys       Date:  1989 Jul-Aug       Impact factor: 4.071

5.  Comparison of internal dose estimates obtained using organ-level, voxel S value, and Monte Carlo techniques.

Authors:  Joshua Grimes; Anna Celler
Journal:  Med Phys       Date:  2014-09       Impact factor: 4.071

6.  Model-based versus specific dosimetry in diagnostic context: comparison of three dosimetric approaches.

Authors:  S Marcatili; D Villoing; T Mauxion; B J McParland; M Bardiès
Journal:  Med Phys       Date:  2015-03       Impact factor: 4.071

7.  Validation of a personalized dosimetric evaluation tool (Oedipe) for targeted radiotherapy based on the Monte Carlo MCNPX code.

Authors:  S Chiavassa; I Aubineau-Lanièce; A Bitar; A Lisbona; J Barbet; D Franck; J R Jourdain; M Bardiès
Journal:  Phys Med Biol       Date:  2006-01-11       Impact factor: 3.609

8.  Absorbed fractions in a voxel-based phantom calculated with the MCNP-4B code.

Authors:  H Yoriyaz; A dos Santos; M G Stabin; R Cabezas
Journal:  Med Phys       Date:  2000-07       Impact factor: 4.071

9.  Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation.

Authors:  Yuni K Dewaraja; Scott J Wilderman; Michael Ljungberg; Kenneth F Koral; Kenneth Zasadny; Mark S Kaminiski
Journal:  J Nucl Med       Date:  2005-05       Impact factor: 10.057

10.  Validation of a dose deposited by low-energy photons using GATE/GEANT4.

Authors:  C O Thiam; V Breton; D Donnarieix; B Habib; L Maigne
Journal:  Phys Med Biol       Date:  2008-05-19       Impact factor: 3.609

View more
  14 in total

1.  Preclinical Pharmacokinetics and Dosimetry Studies of 124I/131I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft Models.

Authors:  Ian R Marsh; Joseph Grudzinski; Dana C Baiu; Abigail Besemer; Reinier Hernandez; Justin J Jeffery; Jamey P Weichert; Mario Otto; Bryan P Bednarz
Journal:  J Nucl Med       Date:  2019-03-29       Impact factor: 10.057

2.  What You See Is Not What You Get: On the Accuracy of Voxel-Based Dosimetry in Molecular Radiotherapy.

Authors:  Johannes Tran-Gia; Maikol Salas-Ramirez; Michael Lassmann
Journal:  J Nucl Med       Date:  2019-12-20       Impact factor: 10.057

3.  Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the Brain.

Authors:  Paul A Clark; Raghava N Sriramaneni; Amber M Bates; Won Jong Jin; Justin C Jagodinsky; Reinier Hernandez; Trang Le; Justin J Jeffery; Ian R Marsh; Joseph J Grudzinski; Eduardo Aluicio-Sarduy; Todd E Barnhart; Bryce R Anderson; Ishan Chakravarty; Ian S Arthur; KyungMann Kim; Jonathan W Engle; Bryan P Bednarz; Jamey P Weichert; Zachary S Morris
Journal:  Radiat Res       Date:  2021-06-01       Impact factor: 2.841

4.  Pretreatment CLR 124 Positron Emission Tomography Accurately Predicts CLR 131 Three-Dimensional Dosimetry in a Triple-Negative Breast Cancer Patient.

Authors:  Abigail E Besemer; Joseph J Grudzinski; Jamey P Weichert; Lance T Hall; Bryan P Bednarz
Journal:  Cancer Biother Radiopharm       Date:  2018-10-23       Impact factor: 3.099

Review 5.  The Radiobiology of Radiopharmaceuticals.

Authors:  Zachary S Morris; Andrew Z Wang; Susan J Knox
Journal:  Semin Radiat Oncol       Date:  2021-01       Impact factor: 5.934

6.  Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy.

Authors:  Justin C Jagodinsky; Won Jong Jin; Amber M Bates; Reinier Hernandez; Joseph J Grudzinski; Ian R Marsh; Ishan Chakravarty; Ian S Arthur; Luke M Zangl; Ryan J Brown; Erin J Nystuen; Sarah E Emma; Caroline Kerr; Peter M Carlson; Raghava N Sriramaneni; Jonathan W Engle; Eduardo Aluicio-Sarduy; Todd E Barnhart; Trang Le; KyungMann Kim; Bryan P Bednarz; Jamey P Weichert; Ravi B Patel; Zachary S Morris
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.600

Review 7.  Development of Targeted Alpha Particle Therapy for Solid Tumors.

Authors:  Narges K Tafreshi; Michael L Doligalski; Christopher J Tichacek; Darpan N Pandya; Mikalai M Budzevich; Ghassan El-Haddad; Nikhil I Khushalani; Eduardo G Moros; Mark L McLaughlin; Thaddeus J Wadas; David L Morse
Journal:  Molecules       Date:  2019-11-26       Impact factor: 4.411

8.  Quantification of internal dosimetry in PET patients: individualized Monte Carlo vs generic phantom-based calculations.

Authors:  Sara Neira; Jacobo Guiu-Souto; Pablo Díaz-Botana; Paulino Pais; Carlos Fernández; Virginia Pubul; Álvaro Ruibal; Cristian Candela-Juan; Araceli Gago-Arias; Miguel Pombar; Juan Pardo-Montero
Journal:  Med Phys       Date:  2020-07-14       Impact factor: 4.071

9.  Individual dosimetry system for targeted alpha therapy based on PHITS coupled with microdosimetric kinetic model.

Authors:  Tatsuhiko Sato; Takuya Furuta; Yuwei Liu; Sadahiro Naka; Shushi Nagamori; Yoshikatsu Kanai; Tadashi Watabe
Journal:  EJNMMI Phys       Date:  2021-01-12

10.  Quantification of internal dosimetry in PET patients II: Individualized Monte Carlo-based dosimetry for [18F]fluorocholine PET.

Authors:  Sara Neira; Jacobo Guiu-Souto; Paulino Pais; Sofía Rodríguez Martínez de Llano; Carlos Fernández; Virginia Pubul; Álvaro Ruibal; Miguel Pombar; Araceli Gago-Arias; Juan Pardo-Montero
Journal:  Med Phys       Date:  2021-07-29       Impact factor: 4.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.